együttműködik Megfelelő megbánás sakre sclc Empirikus zavarjanak kezelése
IJMS | Free Full-Text | Small-Cell Lung Cancer Long-Term Survivor Patients: How to Find a Needle in a Haystack?
YAP drives fate conversion and chemoresistance of small cell lung cancer | Science Advances
FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis | Oncogene
Frontiers | Novel Non-Invasive Radiomic Signature on CT Scans Predicts Response to Platinum-Based Chemotherapy and Is Prognostic of Overall Survival in Small Cell Lung Cancer
YAP1 promotes multidrug resistance of small cell lung cancer by CD74‐related signaling pathways - Song - 2020 - Cancer Medicine - Wiley Online Library
Stable RET expression and signaling in small-cell lung cancer cell... | Download Scientific Diagram
YAP1 promotes multidrug resistance of small cell lung cancer by CD74‐related signaling pathways - Song - 2020 - Cancer Medicine - Wiley Online Library
Multivalent state transitions shape the intratumoral composition of small cell lung carcinoma | Science Advances
SCLC_CellMiner: Integrated Genomics and Therapeutics Predictors of Small Cell Lung Cancer Cell Lines based on their genomic signatures | bioRxiv
Nneha Sakre PhD - Biosafety Specialist II - Stanford University | LinkedIn
JCM | Free Full-Text | Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational Research
Molecular profiles of small cell lung cancer subtypes: Therapeutic implications: Molecular Therapy - Oncolytics
Topological signatures in regulatory network enable phenotypic heterogeneity in small cell lung cancer | eLife
Cancers | Free Full-Text | Transcriptional Profiling Reveals Mesenchymal Subtypes of Small Cell Lung Cancer with Activation of the Epithelial-to-Mesenchymal Transition and Worse Clinical Outcomes
YAP drives fate conversion and chemoresistance of small cell lung cancer | Science Advances
Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers - ScienceDirect
Simultaneously targeting DNA damage repair pathway and mTORC1/2 results in small cell lung cancer growth arrest via ER stress-induced apoptosis
SCLC YAP1 Subtype: Potential for Personalized Therapy? - Small Cell Lung Cancer: Contemporary Concepts
Molecular profiles of small cell lung cancer subtypes: Therapeutic implications - ScienceDirect
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization - ScienceDirect
YAP drives fate conversion and chemoresistance of small cell lung cancer | Science Advances
Prototypical oncogene family Myc defines unappreciated distinct lineage states of small cell lung cancer | Science Advances
Cancers | Free Full-Text | Pathology and Classification of SCLC
A multiplexed in vivo approach to identify driver genes in small cell lung cancer | bioRxiv
Integrative analysis of a large real-world cohort of small cell lung cancer identifies distinct genetic subtypes and insights into histological transformation | bioRxiv
RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR | Oncotarget